Related Experiment Videos
Summary
Younger age, larger tumors, and specific breast cancer locations increase nodal metastasis risk. Patient age, primary tumor size, and lymph node involvement significantly impact survival, aiding prognosis and adjuvant treatment decisions.
Area of Science:
- Oncology
- Biostatistics
- Clinical Medicine
Background:
- Operable breast cancer management requires accurate prognostic factors.
- Understanding variables influencing nodal metastasis and survival is crucial for patient stratification.
Purpose of the Study:
- To identify host and primary tumor variables associated with nodal metastases.
- To determine factors significantly affecting survival in breast cancer patients.
- To define homogeneous risk groups for prognosis and adjuvant therapy decisions.
Main Methods:
- Multivariate statistical analysis of 743 operable breast cancer cases.
- Evaluation of patient age, primary tumor characteristics, and lymph node status.
- Stratification into risk groups based on prognostic variables.
Main Results:
- Younger patients and larger tumors showed higher rates of nodal metastases.
- Axillary tail, upper outer, and central quadrant tumors were linked to increased nodal metastasis.
- Patient age, primary tumor size, and number of metastatic nodes were significant survival predictors.
- Number of involved lymph nodes emerged as the most critical prognostic factor for node-positive patients.
- Tumor site did not significantly influence survival, despite its association with metastasis frequency.
- Distinct risk groups were identified for both node-negative and node-positive patients.
Conclusions:
- Age, primary tumor size, and lymph node status are vital for post-surgical prognosis.
- These factors help identify high-risk patients who may benefit from adjuvant treatment.
- Risk stratification aids in personalized breast cancer management strategies.